" "

Deeptech life growth solutions provider Acculi Labs raises $1.5 million

author-image
ISN Team
New Update
Rupam Das

Rupam Das

Acculi Labs, an AI-based deep-tech life growth solutions provider, has raised $1.5 million in a funding round led by Sabi Holding India at a valuation of $25 million.

With this funding round, the Bengaluru-based startup aims to accelerate the development of its Lyra AI insights system and the Lyfas Udyam project, which includes a sustainable agriculture joint venture between the two companies.

Prior to this round, It had raised Rs 5 crore in a seed funding round in 2020 led by PirE Ventures. 

Purpose of fundraising

Advertisment

The funds will be strategically split, with 50% allocated to the joint venture and the remainder directed towards enhancing Acculi’s diverse offerings.

The startup will focus on improving its manpower, operational efficiency, infrastructure development, and manufacturing and production capacity. 

"We are excited about this funding as it will help drive growth and innovation in our current solutions. With a focus on solving complex problems, this capital will enable us to expand our offerings. Backed by our shared vision, we are looking forward to extending our data power to help Sabi make informed decisions while leveraging their financial tools to strengthen our PAIO," said Sweta U, Head of Lyfas Udyam, and Riyasree, Convenor and Coordinator of PAIO.

Kuldeep, Co-founder of Sabi Holding India, also highlighted the strategic importance of the partnership: “Our partnership with Acculi Labs has been instrumental in our growth. Our shared values and vision align perfectly, thereby making this investment a strategic move. We believe in Acculi's potential and are excited about the future of our joint ventures.”

What does Acculi Labs do?

Founded in May 2017 by Rupam Das and Hari Prasath M, Acculi Labs has evolved significantly from its initial focus on cardiac health assessment to offering a comprehensive suite of health solutions.

The startup's flagship product, Lyfas, is a mobile application capable of non-invasively capturing psychophysiological biomarkers and delivering detailed health reports within three minutes. This approach allows early diagnostics and monitoring for early-stage asymptomatic patients.

The startup's latest development, Lyra, is a conscious AI system that bridges the gap between carbon and silicon life forms.

Additionally, the Lyfas Udyam initiative promotes micro-entrepreneurial circular economies, providing small entrepreneurs with the tools and ecosystem needed to start and run their businesses effectively.

Subscribe